- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07557875
Healing Efficacy of Diode Laser in Lingual Frenectomy
Evaluation of the Healing Efficacy of Diode Laser in Lingual Frenectomy
This study aims to compare the wound healing efficacy and postoperative experiences between the 940 nm diode laser technique and the traditional electrosurgery method for treating ankyloglossia (tongue-tie) in children aged 3 to 6 years.
Participants are randomly assigned to one of two groups: Experimental Group - Patients undergo lingual frenectomy using a 940 nm diode laser and Active Comparator Group - Patients undergo the procedure using conventional high-frequency electrosurgery.
The study evaluates several key outcomes at multiple intervals (24 hours, 3 days, 1 week, and 1 month post-surgery), including: (1) Wound Healing: Measured by the Early Wound Healing Score (EHS); (2) Pain Levels: Assessed using the Wong-Baker FACES Pain Rating Scale; (3) Bleeding Control: Evaluation of intraoperative bleeding; (4) Tongue Mobility: Measurement of free tongue length according to Kotlow's classification.
The goal is to determine if the diode laser provides superior healing, less pain, and better bleeding control compared to electrosurgery.
Přehled studie
Postavení
Podmínky
Detailní popis
Participant Allocation: Participants meeting the inclusion criteria (aged 3-6, diagnosed with Kotlow grade 3 or 4 ankyloglossia) are randomly assigned to one of two groups using a simple randomization method (drawing lots):
- Group 1 (Laser Group): Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase) with a power of 1W (average) and 2W (peak) in pulsed mode (CP2).
- Group 2 (Electrosurgery Group): Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C) in continuous contact mode.
Surgical Procedure: Both groups follow a standardized surgical protocol:
- Anesthesia: Local anesthesia with 2% Lidocaine/Adrenaline (0.45 ml).
- Technique: Transverse incision without suturing or muscle dissection to release the lingual frenum.
- Safety Measures: Use of protective eyewear for the laser group and electrode grounding pads for the electrosurgery group.
Data Collection and Blinding:
- Blinding: This is a single-blind study where the participants and their guardians are unaware of the assigned treatment group. The evaluator measuring post-operative outcomes is also blinded to the surgical method used.
Follow-up Schedule: Evaluations are conducted at five specific intervals:
- Baseline (T0): Pre-operative measurements.
- Post-operative: At 24 hours (T1), 3 days (T2), 1 week (T3), and 1 month (T4).
Evaluation Criteria:
- Wound Healing: Assessed by the Early Wound Healing Score (EHS), focusing on re-epithelialization (CSR), haemostasis (CSH), and inflammation (CSI).
- Pain Intensity: Self-reported by patients using the Wong-Baker FACES Pain Rating Scale.
- Tongue Function: Measuring the increase in free tongue length (mm) using a Quick Tongue-Tie (QTT) tool.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Phong Dai Lam, PhD, DDS
- Telefonní číslo: (+84) 906312958
- E-mail: phonglam@ump.edu.vn
Studijní místa
-
-
-
Ho Chi Minh City, Vietnam
- Nábor
- Children's Hospital 1, Department of Odonto-Stomatology
-
Kontakt:
- Phung Van Ho, DDS
- Telefonní číslo: (+84) 983791484
- E-mail: hvphung.ckii.rhm23@ump.edu.vn
-
Vrchní vyšetřovatel:
- Phung Van Ho, DDS
-
Dílčí vyšetřovatel:
- Phong Dai Lam, PhD, DDS
-
Ho Chi Minh City, Vietnam
- Nábor
- Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
-
Kontakt:
- Phong Dai Lam, PhD, DDS
- Telefonní číslo: (+84) 906312958
- E-mail: phonglam@ump.edu.vn
-
Dílčí vyšetřovatel:
- Phung Van Ho, DDS
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Patients aged between 3 and 6 years.
- Diagnosed with grade 3 or grade 4 ankyloglossia according to Kotlow's classification (1999).
- Parents or legal guardians provide informed consent for the child to participate in the study.
- Patients and guardians agree to follow the follow-up schedule (24 hours, 3 days, 1 week, and 1 month post-surgery).
Exclusion Criteria:
- History of allergy to local anesthetics (e.g., Lidocaine, Adrenaline).
- Patients with systemic diseases or high-risk surgical factors (e.g., cardiovascular disease, bleeding disorders, hemophilia, epilepsy, or uncontrolled asthma).
- Uncooperative patients who are unable to undergo the procedure under local anesthesia or fail to follow post-operative instructions.
- Patients who withdraw from the study before completion.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Trojnásobný
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Diode Laser Group
Patients in this group undergo lingual frenectomy using a 940 nm diode laser (Epic X, Biolase).
The procedure is performed using a transverse incision technique without suturing.
Laser settings include an average power of 1W, peak power of 2W in pulsed mode (CP2), and a 940 nm wavelength.
|
Lingual frenectomy performed using a 940 nm Diode Laser (Epic X, Biolase).
The laser is set to pulsed mode (CP2), average power 1W, and peak power 2W.
The procedure involves a transverse incision to release the frenum without suturing.
Protective eyewear is mandatory for the patient and surgical team.
Ostatní jména:
|
|
Aktivní komparátor: Electrosurgery Group
Patients in this group undergo lingual frenectomy using a high-frequency electrosurgical unit (ERBE-VIO 100C).
The procedure follows the same transverse incision protocol without suturing as the experimental group.
|
Lingual frenectomy performed using a high-frequency electrosurgical unit (ERBE-VIO 100C).
The procedure follows a standardized transverse incision protocol without suturing.
A grounding pad (electrode) is applied to the patient's body to complete the circuit.
This serves as the active comparator representing the conventional surgical method at the hospital.
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Early Wound Healing Score (EHS)
Časové okno: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
The EHS is used to evaluate the early healing of periodontal soft tissue wounds.
It is the sum of three components: Clinical Signs of Re-epithelialization (CSR), Clinical Signs of Haemostasis (CSH), and Clinical Signs of Inflammation (CSI).
The total score ranges from 0 to 10, where a higher score indicates better and faster wound healing (10 being perfect healing).
|
24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Pain Intensity assessed by Wong-Baker FACES Pain Rating Scale
Časové okno: 24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
Patients self-assess their pain levels using a scale of 6 faces representing different pain intensities.
Scores range from 0 (no pain) to 10 (worst possible pain), with increments of 2 (0, 2, 4, 6, 8, 10).
|
24 hours (T1), 3 days (T2), and 1 week (T3) post-surgery.
|
|
Level of Intraoperative Bleeding
Časové okno: During the surgical procedure (T0)
|
Bleeding is assessed during the surgical procedure and categorized into 2 levels: Grade 1 (No bleeding) and Grade 2 (Bleeding present, requiring local haemostatic measures like gauze pressure or laser/electrosurgery coagulation).
|
During the surgical procedure (T0)
|
|
Increase in Free Tongue Length
Časové okno: Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.
|
Measured as the distance (in mm) from the attachment of the lingual frenum on the ventral surface of the tongue to the tip of the tongue using a Quick Tongue-Tie (QTT) measurement tool.
|
Baseline (T0), 1 week (T3), and 1 month (T4) post-surgery.
|
Spolupracovníci a vyšetřovatelé
Publikace a užitečné odkazy
Obecné publikace
- Kotlow LA. Ankyloglossia (tongue-tie): a diagnostic and treatment quandary. Quintessence Int. 1999 Apr;30(4):259-62.
- Hwang WB, Kim DJ, Oh GS, Park JH. Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation. Immune Netw. 2018 Oct 23;18(5):e35. doi: 10.4110/in.2018.18.e35. eCollection 2018 Oct.
- Mazzoni A, Navarro RS, Fernandes KPS, Mesquita-Ferrari RA, Horliana ACRT, Silva T, Santos EM, Sobral APT, Junior AB, Nammour S, Motta LJ, Bussadori SK. Comparison of the Effects of High-Power Diode Laser and Electrocautery for Lingual Frenectomy in Infants: A Blinded Randomized Controlled Clinical Trial. J Clin Med. 2022 Jun 30;11(13):3783. doi: 10.3390/jcm11133783.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Bolest
- Neurologické projevy
- Stomatognátní onemocnění
- Rány a zranění
- Pooperační komplikace
- Patologické procesy
- Změny tělesné teploty
- Poruchy tepelného stresu
- Patologické stavy, příznaky a symptomy
- Příznaky a symptomy
- Hypertermie
- Ankyloglossie
- Bolest, pooperační
- Vybavení a potřeby
- Lasery
- Optická zařízení
- Radiační zařízení a potřeby
- Lasery, polovodič
Další identifikační čísla studie
- IRB00010293-2026
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .